SG Americas Securities’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-5,899
| Closed | -$106K | – | 3242 |
|
|
2020
Q2 | $106K | Sell |
5,899
-20,623
| -78% | -$371K | ﹤0.01% | 2900 |
|
|
2020
Q1 | $189K | Buy |
26,522
+16,255
| +158% | +$116K | ﹤0.01% | 2139 |
|
|
2019
Q4 | $245K | Buy |
+10,267
| New | +$245K | ﹤0.01% | 2014 |
|
|
2019
Q2 | – | Sell |
-6,645
| Closed | -$231K | – | 3024 |
|
|
2019
Q1 | $231K | Sell |
6,645
-14,412
| -68% | -$501K | ﹤0.01% | 2165 |
|
|
2018
Q4 | $411K | Buy |
+21,057
| New | +$411K | ﹤0.01% | 1706 |
|
|
2018
Q3 | – | Sell |
-3,739
| Closed | -$141K | – | 3002 |
|
|
2018
Q2 | $141K | Sell |
3,739
-187
| -5% | -$7.05K | ﹤0.01% | 2486 |
|
|
2018
Q1 | $128K | Buy |
+3,926
| New | +$128K | ﹤0.01% | 2337 |
|
|
2017
Q4 | – | Sell |
-6,079
| Closed | -$328K | – | 3154 |
|
|
2017
Q3 | $328K | Sell |
6,079
-2,555
| -30% | -$138K | ﹤0.01% | 1875 |
|
|
2017
Q2 | $485K | Buy |
+8,634
| New | +$485K | ﹤0.01% | 1687 |
|
|
2017
Q1 | – | Sell |
-4,553
| Closed | -$102K | – | 3098 |
|
|
2016
Q4 | $102K | Sell |
4,553
-140,802
| -97% | -$3.15M | ﹤0.01% | 2529 |
|
|
2016
Q3 | $3.3M | Buy |
+145,355
| New | +$3.3M | 0.03% | 442 |
|
|
2016
Q2 | – | Sell |
-60,487
| Closed | -$1.23M | – | 2618 |
|
|
2016
Q1 | $1.23M | Buy |
60,487
+58,382
| +2,773% | +$1.19M | 0.01% | 1070 |
|
|
2015
Q4 | $108K | Sell |
2,105
-7,917
| -79% | -$406K | ﹤0.01% | 2048 |
|
|
2015
Q3 | $427K | Buy |
+10,022
| New | +$427K | ﹤0.01% | 1115 |
|
|
2015
Q2 | – | Sell |
-6,742
| Closed | -$256K | – | 2411 |
|
|
2015
Q1 | $256K | Sell |
6,742
-1,088
| -14% | -$41.3K | ﹤0.01% | 1543 |
|
|
2014
Q4 | $222K | Buy |
+7,830
| New | +$222K | ﹤0.01% | 2086 |
|
|
2014
Q1 | – | Sell |
-977,990
| Closed | -$25.2M | – | 2394 |
|
|
2013
Q4 | $25.2M | Buy |
+977,990
| New | +$25.2M | 0.1% | 187 |
|